For Fragments Based Innovations
 
 
 
 
Products
Rare Organics
Structure Product Information
ETH106
Ethanone, 2-bromo-1-cyclopropyl-2-(4-fluorophenyl)-
ETH107
Ethanone, 2-bromo-1-cyclopropyl-2-(3-fluorophenyl)-
ETH108
Ethanesulfonamide, N-[2,4-dichloro-5-[4-(difluoromethyl)-4,5-dihydro-3-methyl-5-oxo-1H-1,2,4-triazol-1-yl]phenyl]-
[122836-40-2]
ETH109
Ethanone, 2-chloro-1-cyclopropyl-2-(2-fluorophenyl)-
[178688-43-2]
ETH110
1,2-Ethanediamine, N-(2,3-dichlorophenyl)-N'-[2-[(2,3-dichlorophenyl)amino]ethyl]-
ETH111
Ethanone, 1-cyclopropyl-2-phenyl-
[14113-94-1]
ETH112
Ethanone, 2,2-dichloro-1-cyclopropyl-2-(2-fluorophenyl)-
ETH113
Ethanaminium bromide, 2-oxo-2-(4-allyl-2-methoxyphenoxy)-N,N,N-trimethyl-
ETH114
Ethanol, 2-(triphenylmethoxy)-, trifluoromethanesulfonate
ETH115
Ethanone, 2-[2-(acetyloxy)-6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl]-1-cyclopropyl-2-phenyl-
[1391194-45-8]
ETH116
Ethanone, 2-[2-(acetyloxy)-6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl]-1-cyclopropyl-2-(3-fluorophenyl)-
[1391194-39-0]
ETH117
Ethanone, 2-[2-(acetyloxy)-6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl]-1-cyclopropyl-2-(4-fluorophenyl)-
[1391194-50-5]
ETH118
Ethanone, 1-cyclopropyl-2-[6,7-dihydro-2-(1-oxopropoxy)thieno[3,2-c]pyridin-5(4H)-yl]-2-(2-fluorophenyl)-
[150322-44-4]
ETH119
Ethanone, 1-(5-chloro-2-thienyl)-
[6310-09-4]
ETH120
1-Ethanaminium ,2-oxo-2C-[(R)-2',5,7,8-tetramethyl-2'-((4S,8S)-4,8,12-trimethyltridecyl)chroman-6-yloxy)],N,N,N-trimethyl-, chloride (1:1)
FOR001
Formamide, N-(2-formylphenyl)-
[25559-38-0]
FOR004
Formamide, N-[1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutyl]-
[84467-85-6]
FRU007
-D-Fructopyranose 2,3:4,5-bis-O-(1-methylethylidene)-, 4-methylbenzenesulfonate
[78574-35-3]
FRU008
-D-Fructopyranose, 1-amino-1-deoxy-2,3:4,5-bis-O-(1-methylethylidene)-
[128316-82-5]
FRU009
-D-Fructopyranose, 2,3:4,5-bis-O-(1-methylethylidene)-, 1-sulfamate
[97240-79-4]
Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes patent infringement and its liability is at buyer's risk. 
Page [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119]

 


New products

Copyright © 2010-2015 Fragmenta. All rights reserved.  Terms of Use | Order and Payment Terms | Help